SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
64 days-78 days |
6 |
246.1 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84786 |
1602 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
70 days-84 days |
6 |
172.8 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84798 |
1602 |
SD |
body weight |
acetaminophen (500 mg/kg) (for 1 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
42 days-56 days |
6 |
134.7 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84804 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 15 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
57 days-71 days |
6 |
153.9 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84821 |
1602 |
SD |
body weight |
acetaminophen (500 mg/kg) (for 22 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
64 days-78 days |
6 |
241.1 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84773 |
1602 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
42 days-56 days |
6 |
184.1 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84781 |
1602 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
57 days-71 days |
6 |
151.6 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84816 |
1602 |
SD |
body weight |
control condition |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
body mass |
female |
0 days
| 8 |
305.4 |
g |
5.3 |
14.99 |
body weighing method |
0.0 |
- |
0 |
days |
100631 |
2499 |
SD |
body weight |
left nephrectomy then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (40 mg/kg) |
Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. |
body mass |
male |
0 days
| 7 |
257.0 |
g |
4.0 |
10.58 |
body weighing method |
0.0 |
unx |
0 |
|
98926 |
2179 |
SD |
body weight |
left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (40 mg/kg) |
Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. |
body mass |
male |
0 days
| 7 |
386.0 |
g |
7.0 |
18.52 |
body weighing method |
0.0 |
unx |
56 |
days |
98934 |
2179 |
SD |
body weight |
sham surgical control condition (for 140 days) |
Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. |
body mass |
male |
189 days
| 6 |
532.2 |
g |
20.4 |
49.97 |
body weighing method |
0.0 |
sham lad occlusion |
140 |
days |
101078 |
2564 |
SD |
body weight |
control condition |
Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904. |
body mass |
female |
96 days-121 days |
7 |
201.0 |
g |
4.91 |
13.0 |
body weighing method |
0.0 |
|
0 |
|
110176 |
3166 |
SD |
body weight |
artificial aortocaval fistula (for 6 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
body mass |
male |
0 days
| 6 |
302.0 |
g |
5.0 |
12.25 |
body weighing method |
1.0 |
ACF |
360 |
min |
98755 |
2160 |
SD |
body weight |
unilateral nephrectomy (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 11 |
277.0 |
g |
8.14 |
27.0 |
body weighing method |
0.0 |
unx |
13 |
days |
101536 |
2602 |
SD |
body weight |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 7 |
309.0 |
g |
18.9 |
50.0 |
body weighing method |
0.0 |
unx |
28 |
days |
101572 |
2602 |
SD |
body weight |
unilateral nephrectomy (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 8 |
315.0 |
g |
9.55 |
27.0 |
body weighing method |
0.0 |
unx |
28 |
days |
101607 |
2602 |
SD |
body weight |
acetaminophen (500 mg/kg) (for 8 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
50 days-64 days |
6 |
209.3 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84771 |
1602 |
SD |
body weight |
left nephrectomy then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (40 mg/kg) |
Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. |
body mass |
male |
0 days
| 9 |
258.0 |
g |
3.0 |
9.0 |
body weighing method |
0.0 |
unx |
0 |
|
98927 |
2179 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
64 days-78 days |
6 |
242.6 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84763 |
1602 |
SD |
body weight |
acetaminophen (250 mg/kg) (for 8 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
50 days-64 days |
6 |
211.0 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84766 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
70 days-84 days |
6 |
262.4 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84779 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 22 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
64 days-78 days |
6 |
246.8 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84778 |
1602 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
70 days-84 days |
6 |
255.5 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84788 |
1602 |
SD |
body weight |
acetaminophen (250 mg/kg) (for 1 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
42 days-56 days |
6 |
136.3 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84799 |
1602 |
SD |
body weight |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
70 days-84 days |
6 |
175.3 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84803 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 8 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
50 days-64 days |
6 |
146.1 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84820 |
1602 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
57 days-71 days |
6 |
225.6 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84762 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 1 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
42 days-56 days |
6 |
139.0 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84819 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
70 days-84 days |
6 |
166.7 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84813 |
1602 |
SD |
body weight |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
body mass |
female |
0 days
| 10 |
291.9 |
g |
6.4 |
20.24 |
body weighing method |
0.0 |
unx |
97 |
days |
100634 |
2499 |
SD |
body weight |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
body mass |
male |
0 days
| 8 |
526.0 |
g |
10.25 |
29.0 |
body weighing method |
0.0 |
stz |
154 |
days |
99871 |
2358 |
SD |
body weight |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 7 |
307.0 |
g |
36.66 |
25.0 |
body weighing method |
0.0 |
unx |
28 |
days |
101573 |
2602 |
SD |
body weight |
unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 8 |
300.0 |
g |
10.96 |
31.0 |
body weighing method |
0.0 |
unx |
28 |
days |
101608 |
2602 |
SD |
body weight |
left anterior descending coronary artery occlusion (for 140 days) |
Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. |
body mass |
male |
189 days
| 10 |
568.3 |
g |
34.1 |
107.83 |
body weighing method |
0.0 |
lad occlusion |
140 |
days |
101077 |
2564 |
SD |
body weight |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
body mass |
male |
98 days
| 8 |
354.0 |
g |
9.0 |
25.46 |
scale |
0.0 |
ACF |
28 |
days |
99192 |
2278 |
SD |
body weight |
sham surgical control condition (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
body mass |
male |
175 days
| 10 |
471.0 |
g |
10.0 |
31.62 |
scale |
0.0 |
sham ACF |
105 |
days |
99193 |
2278 |
SD |
body weight |
artificial aortocaval fistula (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
body mass |
male |
175 days
| 10 |
489.0 |
g |
15.0 |
47.43 |
scale |
0.0 |
ACF |
105 |
days |
99194 |
2278 |
SD |
body weight |
streptozotocin (60 mg/kg) then insulin |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
body mass |
male |
0 days
| 8 |
588.0 |
g |
27.58 |
78.0 |
body weighing method |
0.0 |
stz |
224 |
days |
99914 |
2358 |
SD |
body weight |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
body mass |
male |
0 days
| 8 |
570.0 |
g |
31.47 |
89.0 |
body weighing method |
0.0 |
stz |
224 |
days |
99915 |
2358 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
50 days-64 days |
6 |
205.4 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84782 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 8 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
50 days-64 days |
6 |
147.0 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84810 |
1602 |
SD |
body weight |
in utero condition (for 7 days) and dibutyl phthalate (850 mg/kg/d) (for 7 days) |
Jiang JT, et al., Toxicology. 2015 Dec 2;338:77-85. doi: 10.1016/j.tox.2015.10.006. Epub 2015 Oct 26. |
body mass |
male |
1 days
| 43 |
4.9 |
g |
0.06 |
0.39 |
body weighing method |
1.0 |
|
0 |
|
98735 |
2158 |
SD |
body weight |
sham surgical control condition (for 12 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
body mass |
male |
0 days
| 6 |
271.0 |
g |
6.0 |
14.7 |
body weighing method |
1.0 |
sham ACF |
720 |
min |
98772 |
2160 |
SD |
body weight |
sham surgical control condition (for 2 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
body mass |
male |
0 days
| 6 |
282.0 |
g |
16.0 |
39.19 |
body weighing method |
1.0 |
sham ACF |
2 |
days |
98774 |
2160 |
SD |
body weight |
left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (40 mg/kg) |
Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. |
body mass |
male |
0 days
| 7 |
318.0 |
g |
15.0 |
39.69 |
body weighing method |
0.0 |
unx |
56 |
days |
98932 |
2179 |
SD |
body weight |
control condition |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
body mass |
male |
0 days
| 8 |
675.0 |
g |
12.37 |
35.0 |
body weighing method |
0.0 |
|
0 |
|
99892 |
2358 |
SD |
body weight |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
70 days-84 days |
6 |
258.5 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84769 |
1602 |
SD |
body weight |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
70 days-84 days |
6 |
256.6 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84774 |
1602 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
57 days-71 days |
6 |
156.6 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84796 |
1602 |
SD |
body weight |
acetaminophen (250 mg/kg) (for 15 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
57 days-71 days |
6 |
161.2 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84801 |
1602 |
SD |
body weight |
acetaminophen (250 mg/kg) (for 22 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
64 days-78 days |
6 |
170.0 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84802 |
1602 |
SD |
body weight |
acetaminophen (500 mg/kg) (for 8 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
50 days-64 days |
6 |
147.9 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84805 |
1602 |
SD |
body weight |
acetaminophen (500 mg/kg) (for 15 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
57 days-71 days |
6 |
151.9 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84806 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 1 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
42 days-56 days |
6 |
134.2 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84809 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
70 days-84 days |
6 |
164.5 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84823 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 15 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
57 days-71 days |
6 |
150.9 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84811 |
1602 |
SD |
body weight |
acetaminophen (500 mg/kg) (for 22 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
64 days-78 days |
6 |
157.7 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84807 |
1602 |
SD |
body weight |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then paricalcitol (0.8 mg/kg) (for 90 days) and enalapril (25 mg/l) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
body mass |
female |
0 days
| 12 |
290.6 |
g |
6.8 |
23.56 |
body weighing method |
0.0 |
unx |
97 |
days |
100635 |
2499 |
SD |
body weight |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 5 |
285.0 |
g |
6.71 |
15.0 |
body weighing method |
0.0 |
unx |
13 |
days |
101537 |
2602 |
SD |
body weight |
unilateral nephrectomy (for 28 days) then enalapril (50 mg/l) (for 28 days) and losartan (180 mg/l) (for 28 days) and aldosterone (35 mg/kg/d) (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 6 |
312.0 |
g |
9.8 |
24.0 |
body weighing method |
0.0 |
unx |
28 |
days |
101574 |
2602 |
SD |
body weight |
artificial aortocaval fistula (for 5 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
body mass |
male |
0 days
| 6 |
281.0 |
g |
4.0 |
9.8 |
body weighing method |
1.0 |
ACF |
5 |
days |
98775 |
2160 |
SD |
body weight |
left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (40 mg/kg) |
Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. |
body mass |
male |
0 days
| 7 |
267.0 |
g |
7.0 |
18.52 |
body weighing method |
0.0 |
unx |
70 |
days |
98935 |
2179 |
SD |
body weight |
left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (40 mg/kg) |
Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. |
body mass |
male |
0 days
| 7 |
346.0 |
g |
17.0 |
44.98 |
body weighing method |
0.0 |
unx |
70 |
days |
98937 |
2179 |
SD |
body weight |
control condition |
Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. |
body mass |
male |
90 days
| 9 |
396.0 |
g |
7.6 |
22.8 |
body weighing method |
0.0 |
|
0 |
|
101214 |
2582 |
SD |
body weight |
control condition |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
body mass |
male |
0 days
| 8 |
738.0 |
g |
27.93 |
79.0 |
body weighing method |
0.0 |
|
0 |
|
99916 |
2358 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
64 days-78 days |
6 |
159.1 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84817 |
1602 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
57 days-71 days |
6 |
228.0 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84784 |
1602 |
SD |
body weight |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then enalapril (25 mg/l) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
body mass |
female |
0 days
| 12 |
281.9 |
g |
4.2 |
14.55 |
body weighing method |
0.0 |
unx |
97 |
days |
100633 |
2499 |
SD |
body weight |
left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (40 mg/kg) |
Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. |
body mass |
male |
0 days
| 7 |
301.0 |
g |
5.0 |
13.23 |
body weighing method |
0.0 |
unx |
28 |
days |
98929 |
2179 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 1 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
42 days-56 days |
6 |
182.4 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84775 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 8 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
50 days-64 days |
6 |
211.6 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84776 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 1 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
42 days-56 days |
6 |
190.7 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84789 |
1602 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
50 days-64 days |
6 |
148.3 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84795 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
70 days-84 days |
6 |
264.0 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84793 |
1602 |
SD |
body weight |
acetaminophen (250 mg/kg) (for 8 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
50 days-64 days |
6 |
152.8 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84800 |
1602 |
SD |
body weight |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
70 days-84 days |
6 |
162.5 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84808 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 22 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
64 days-78 days |
6 |
160.7 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84822 |
1602 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
50 days-64 days |
6 |
207.4 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84761 |
1602 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
50 days-64 days |
6 |
143.7 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84815 |
1602 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
70 days-84 days |
6 |
160.5 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84818 |
1602 |
SD |
body weight |
in utero condition (for 7 days) and corn oil (for 7 days) |
Jiang JT, et al., Toxicology. 2015 Dec 2;338:77-85. doi: 10.1016/j.tox.2015.10.006. Epub 2015 Oct 26. |
body mass |
male |
1 days
| 0 |
6.34 |
g |
|
0.34 |
body weighing method |
1.0 |
|
0 |
|
98736 |
2158 |
SD |
body weight |
sham surgical control condition (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 6 |
336.0 |
g |
6.53 |
16.0 |
body weighing method |
0.0 |
sham unx |
13 |
days |
101535 |
2602 |
SD |
body weight |
unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) and aldosterone (30-40 mg/kg/d) (between 12 and 14 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 5 |
302.0 |
g |
6.26 |
14.0 |
body weighing method |
0.0 |
unx |
13 |
days |
101538 |
2602 |
SD |
body weight |
left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (40 mg/kg) |
Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. |
body mass |
male |
0 days
| 9 |
300.0 |
g |
5.0 |
15.0 |
body weighing method |
0.0 |
unx |
28 |
days |
98930 |
2179 |
SD |
body weight |
control condition |
Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. |
body mass |
male |
420 days-450 days |
9 |
572.0 |
g |
14.4 |
43.2 |
body weighing method |
0.0 |
|
0 |
|
101215 |
2582 |
SD |
body weight |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
body mass |
male |
98 days
| 8 |
359.0 |
g |
20.0 |
56.57 |
scale |
0.0 |
sham ACF |
28 |
days |
99191 |
2278 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
42 days-56 days |
6 |
180.4 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84760 |
1602 |
SD |
body weight |
sham surgical control condition (between 120 and 12 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
body mass |
male |
0 days
| 6 |
284.0 |
g |
4.0 |
9.8 |
body weighing method |
1.0 |
sham ACF |
5 |
days |
98776 |
2160 |
SD |
body weight |
acetaminophen (250 mg/kg) (for 15 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
57 days-71 days |
6 |
227.7 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84767 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 15 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
57 days-71 days |
6 |
229.6 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84777 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 8 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
50 days-64 days |
6 |
208.8 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84790 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 15 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
57 days-71 days |
6 |
231.9 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84791 |
1602 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
42 days-56 days |
6 |
136.2 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84794 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 22 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
64 days-78 days |
6 |
252.7 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84792 |
1602 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
64 days-78 days |
6 |
167.0 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84797 |
1602 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
42 days-56 days |
6 |
137.3 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84814 |
1602 |
SD |
body weight |
acetaminophen (500 mg/kg) (for 15 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
57 days-71 days |
6 |
229.6 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84772 |
1602 |
SD |
body weight |
controlled calcium content diet (0.6 %) (for 97 days) and controlled content diet (0.9 %) (for 97 days) and unilateral nephrectomy (for 97 days) then vehicle control condition (100 ul) (for 90 days) |
Finch JL, et al., Am J Physiol Renal Physiol. 2011 Sep 28. |
body mass |
female |
0 days
| 13 |
283.6 |
g |
3.8 |
13.7 |
body weighing method |
0.0 |
unx |
97 |
days |
100632 |
2499 |
SD |
body weight |
sham surgical control condition (for 28 days) |
Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. |
body mass |
male |
0 days
| 6 |
347.0 |
g |
7.35 |
18.0 |
body weighing method |
0.0 |
sham unx |
28 |
days |
101571 |
2602 |
SD |
body weight |
artificial aortocaval fistula (for 2 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
body mass |
male |
0 days
| 6 |
291.0 |
g |
6.0 |
14.7 |
body weighing method |
1.0 |
ACF |
2 |
days |
98773 |
2160 |
SD |
body weight |
artificial aortocaval fistula (for 12 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
body mass |
male |
0 days
| 6 |
267.0 |
g |
4.0 |
9.8 |
body weighing method |
1.0 |
ACF |
720 |
min |
98771 |
2160 |
SD |
body weight |
left nephrectomy then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (40 mg/kg) |
Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. |
body mass |
male |
0 days
| 7 |
256.0 |
g |
3.0 |
7.94 |
body weighing method |
0.0 |
unx |
0 |
|
98928 |
2179 |
SD |
body weight |
left nephrectomy (for 28 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (40 mg/kg) |
Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. |
body mass |
male |
0 days
| 7 |
296.0 |
g |
11.0 |
29.1 |
body weighing method |
0.0 |
unx |
28 |
days |
98931 |
2179 |
SD |
body weight |
left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (40 mg/kg) |
Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. |
body mass |
male |
0 days
| 9 |
308.0 |
g |
10.0 |
30.0 |
body weighing method |
0.0 |
unx |
56 |
days |
98933 |
2179 |
SD |
body weight |
left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (40 mg/kg) |
Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. |
body mass |
male |
0 days
| 9 |
281.0 |
g |
15.0 |
45.0 |
body weighing method |
0.0 |
unx |
70 |
days |
98936 |
2179 |
SD |
body weight |
streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) |
Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. |
body mass |
male |
0 days
| 8 |
563.0 |
g |
12.37 |
35.0 |
body weighing method |
0.0 |
stz |
154 |
days |
99891 |
2358 |
SD |
body weight |
left anterior descending coronary artery occlusion (for 28 days) |
Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. |
body mass |
male |
77 days
| 6 |
403.2 |
g |
7.4 |
18.13 |
body weighing method |
0.0 |
lad occlusion |
28 |
days |
101075 |
2564 |
SD |
body weight |
sham surgical control condition (for 28 days) |
Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. |
body mass |
male |
77 days
| 6 |
378.1 |
g |
12.1 |
29.64 |
body weighing method |
0.0 |
sham lad occlusion |
28 |
days |
101076 |
2564 |
SD |
body weight |
sham surgical control condition (for 6 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
body mass |
male |
0 days
| 6 |
291.0 |
g |
10.0 |
24.49 |
body weighing method |
1.0 |
sham ACF |
360 |
min |
98756 |
2160 |
SD |
body weight |
doxorubicin (5 mg/kg) (between 6 and 7 days) |
Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904. |
body mass |
female |
96 days-121 days |
7 |
192.0 |
g |
2.65 |
7.0 |
body weighing method |
0.0 |
|
0 |
|
110178 |
3166 |
SD |
body weight |
acetaminophen (250 mg/kg) (for 22 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
64 days-78 days |
6 |
244.0 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84768 |
1602 |
SD |
body weight |
acetaminophen (500 mg/kg) (for 1 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
42 days-56 days |
6 |
181.7 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84770 |
1602 |
SD |
body weight |
acetaminophen (250 mg/kg) (for 1 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
42 days-56 days |
6 |
182.3 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84765 |
1602 |
SD |
body weight |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
male |
70 days-84 days |
6 |
257.3 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84764 |
1602 |
SD |
body weight |
acetaminophen (1000 mg/kg) (for 22 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
body mass |
female |
64 days-78 days |
6 |
157.9 |
g |
|
|
body weighing method |
0.0 |
|
0 |
|
84812 |
1602 |